Ten63 Therapeutics Company
Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the most lethal diseases. It combines low-residual, ML-based computational chemistry and mathematically guaranteed, superlinear search algorithms to find optimized drug candidates. The company's platform, COPPER, leverages its proprietary AI and state-of-the-art physical models to explore an unprecedentedly large chemical space, allowing them to discover new therapeutics to targets previously believed undruggable.
Headquarters:
United States
Industry:
Drug Discovery & Molecular Sim
Super Industry:
Quantum Medicine
Funding Total Value:
15900000
Founders:
Jonathan Jou,Marcel Frenkel,Mark Hallen